Guangzhou Wondfo Biotech Co., Ltd. Class A 300482

SZSE · China · Health Technology

CNY 16.76+0.44 (+2.70%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Guangzhou Wondfo Biotech Co., Ltd. Class A 300482

SZSE · China · Health Technology

CNY 16.76+0.44 (+2.70%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-9.31% · 6MFull-screen chart

Open CNY 16.36High CNY 16.84Low CNY 16.33Close CNY 16.76Volume 6.35M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 16.32
Day range: CNY 16.33 – CNY 16.84
52-week range: CNY 15.40 – CNY 26.29
Volume: 6.35M
Market cap: CNY 7.78B
Dividend yield (annualized): 1.31%
Next earnings date: 2026-10-23
Avg. volume (1Y): 7.95M

Performance

1 week

+1.02%

1 month

+2.13%

3 months

-1.59%

6 months

-4.67%

Year to date

-15.87%

1 year

-20.29%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: China
Exchange: SZSE
Shares outstanding: 466.72M
Employees: 2,443
ISIN: CNE100002102
Beta: 1.42

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceAug 12, 2026

Guangzhou Wondfo Biotech Co Ltd - Product Pipeline Analysis, 2026 Update Now Available — 143-Page Review of All Pipeline Products by Equipment Type, Indication, and Development Stage

Opportunities include expanding rapid, molecular and automated diagnostics for clinical testing, chronic disease management, epidemic monitoring and personal health, plus market entry, partnerships, licensing and acquisitions around promising pipeline products.Dublin, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The "Guangzhou Wondfo Biotech Co Ltd (300482) - Product Pipeline Analysis, 2026 Update" has been added to ResearchAndMarkets.com's offering. Guangzhou Wondfo Biotech Co Ltd (Wondfo), headquartered

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.